Seiya Sato - Concepedia

Author

Seiya Sato

Tottori University ORCID

Also Known As

Kazunori Uegaki, S Sato, S. Sato, SEIYA SATO, Sato Seiya, Sato, Seiya, Seiya SATO, Seiya Sato, Sultana Razia

167

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Tottori University Tottori University Hospital Shinshu University Iwate Medical University Shimane University

About

Seiya Sato is an author at Tottori University specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	22	664
2	Health Sciences	4	4	213
3	Engineering	1	1	18
4	Natural Sciences	1	1	18
5	Public Health	1	1	23

Seiya Sato

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy Seiya Sato, Hiroaki Itamochi Therapeutic Advances in Medical Oncology Surgical OncologyAdvanced EocCancer ManagementGynecologySurgery	2014	92
<i>CCN3</i> Inhibits Neointimal Hyperplasia Through Modulation of Smooth Muscle Cell Growth and Migration Tatsushi Shimoyama, Shûichi Hiraoka, Minoru Takemoto, Arteriosclerosis Thrombosis and Vascular Biology	2010	83
Combination chemotherapy of oxaliplatin and 5‐fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy Seiya Sato, Hiroaki Itamochi, Junzo Kigawa, Cancer Science Cancer ManagementGynecologyPathologyTumor BiologyOvarian Cancer	2008	80
Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer Hiroaki Komatsu, Tetsuro Oishi, Hiroaki Itamochi, International Journal of Gynecological Cancer	2017	80
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions Ryo Tamura, Kosuke Yoshihara, Tetsuya Saito, Oncogenesis	2018	64
Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502 S Sadahiro, Takashi Tsuchiya, Koichi Sasaki, Annals of Oncology UrologyOncologyGastrointestinal OncologyMedicinePhase Iii Trial	2015	53
Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy Imari Deura, Muneaki Shimada, Keiko Hirashita, International Journal of Clinical Oncology Gynecologic Cancer SurgerySurgeryMedicineRisk FactorsOrthopaedic Surgery	2014	53
Checkpoint Kinase Inhibitor AZD7762 Overcomes Cisplatin Resistance in Clear Cell Carcinoma of the Ovary Hiroaki Itamochi, Mayumi Nishimura, Nao Oumi, International Journal of Gynecological Cancer	2013	43
The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma Tetsuro Oishi, Hiroaki Itamochi, Akiko Kudoh, Oncology Reports	2014	42
Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary Tetsuro Oishi, Hiroaki Itamochi, Junzo Kigawa, International Journal of Gynecological Cancer	2007	40

Page 1